Can Testosterone Affect Cholesterol?
Long before anyone starts TRT, natural testosterone level correlates with lipid profile in population studies — lower testosterone is linked to higher triglycerides and lower HDL. We explain this broader, epidemiological relationship and why it shouldn't be confused with the specific effect of testosterone therapy itself.
Number of studies
1
Safety
Requires caution
Time to effects
Not applicable — this is an interpretive question, not an intervention.
Who it's for
Table of contents
TL;DR
Long before anyone starts TRT, natural testosterone level correlates with lipid profile in population studies — lower testosterone is linked to higher triglycerides and lower HDL. We explain this broader, epidemiological relationship and why it shouldn't be confused with the specific effect of testosterone therapy itself.
- →Helps understand the broader, population-level context of the testosterone–lipids relationship, independent of any decision about TRT
- →Teaches caution about simple causal conclusions drawn from observational studies
- →Makes it easier to distinguish this general epidemiological relationship from the specific, pharmacological effect of testosterone therapy itself
| Type of question | The epidemiological relationship of natural testosterone with lipids, not the effect of TRT |
|---|---|
| Level of evidence | Moderate — consistent observational data, limited data on the direction of causality |
| Who it applies to | Men analyzing their own lipid panel and testosterone outside the context of hormone therapy |
| Key mechanism | Partly shared underlying factors (visceral obesity, insulin resistance, low SHBG), not just a direct hormone effect |
| What to do next | The specific pharmacological effect of TRT on the lipid panel — see our separate entry "TRT and Cholesterol" |
| Status | An active area of epidemiological research; the direction of causality is not fully resolved |
Understand
Overview
The question "can testosterone affect cholesterol" has two different answers depending on which testosterone we mean. The first concerns what happens in a population of men who have never used any hormone therapy — here testosterone is a natural variable that differs between people for many reasons (age, body weight, lifestyle, genetics). The second concerns what happens when testosterone is raised deliberately, pharmacologically, as part of replacement therapy (TRT). This entry focuses solely on the first question — the broader, epidemiological relationship between natural, endogenous testosterone level and lipid profile in the general population, not on what specifically changes as a result of starting TRT.
Observational data from large population studies are fairly consistent on this point. A Finnish study of more than 1,600 men aged 40–69 found that natural testosterone level correlated positively with HDL (so-called "good cholesterol") and negatively with triglycerides and total cholesterol, though not with LDL. In other words: men with lower natural testosterone in this study had a statistically worse, more atherogenic lipid profile — higher triglycerides and lower HDL — than men with higher testosterone. Similar directions of association are confirmed in studies from other populations, including Taiwanese and Chinese cohorts, making this one of the more reproducible observations in the endocrinology literature.
A key caveat that's easy to miss concerns the direction of causality. Low testosterone and an unfavorable lipid profile don't occur in a vacuum — both correlate strongly with obesity, especially visceral obesity, insulin resistance, and metabolic syndrome. Visceral fat tissue lowers testosterone (partly through increased aromatization to estradiol and lower SHBG) while itself worsening the lipid profile independent of hormone level. This means part, and perhaps even most, of the observed correlation between testosterone and lipids in population studies may reflect a shared underlying cause (excess fat tissue, insulin resistance) rather than a direct, causal effect of testosterone itself on the liver and lipoprotein metabolism. Cross-sectional studies, such as the ones cited above, cannot by their nature fully resolve this direction of causality.
It's worth clearly distinguishing this broad, population-level relationship from the question of what specifically changes, and in which direction, in the lipid panel when a man with low testosterone starts replacement therapy. That's an entirely different, well-described topic covered in separate interventional studies — involving the specific direction and magnitude of changes in LDL, HDL, and triglycerides under pharmacologically raised testosterone, as well as data from large randomized trials (including TRAVERSE) assessing whether these changes translate into real cardiovascular risk. We cover this full, detailed picture of TRT's pharmacological effect on the lipid panel separately, in our entry "TRT and Cholesterol" — that's also where you'll find specific numerical data on the direction and magnitude of changes under therapy.
Mechanism of action
The mechanisms behind the population-level correlation between natural testosterone and lipids differ from the pharmacological mechanisms described for TRT. In the general population, testosterone and SHBG (sex hormone-binding globulin) are closely linked, and low SHBG on its own is a marker of insulin resistance and metabolic syndrome, strongly correlated with an unfavorable lipid profile independent of testosterone itself. This makes it hard, in observational studies, to fully separate the effect attributed to testosterone from the effect attributed to the accompanying metabolic disturbances.
A second mechanism involves body composition as a mediating variable. Men with lower natural testosterone more often have a higher share of visceral fat, and it's this tissue — through increased release of free fatty acids into portal circulation and heightened hepatic insulin resistance — that is one of the main, testosterone-independent drivers of higher triglycerides and lower HDL. Reducing visceral fat, regardless of whether it's accompanied by a rise in testosterone, improves the lipid profile on its own.
This differs fundamentally from the pharmacological mechanisms triggered by exogenous testosterone given as TRT — there, the key role is played by the androgen's direct effect on hepatic lipase activity (which speeds HDL breakdown) and on hepatic LDL receptor expression, i.e. mechanisms acting at the level of the liver itself, not just indirectly through a change in body composition. These pharmacological mechanisms, along with the specific direction and magnitude of changes observed after starting therapy, are covered in detail in our separate entry "TRT and Cholesterol."
Population-level correlation
Lower natural testosterone correlates with higher triglycerides and lower HDL in large observational studies of men.
Shared metabolic background
Visceral obesity and insulin resistance simultaneously lower testosterone and worsen the lipid profile, making direct causality hard to establish.
SHBG's role as a mediating variable
Low SHBG, strongly tied to metabolic syndrome, correlates with both lower testosterone and a worse lipid profile independent of the hormone itself.
Evidence: moderate — based on 1 study in this database.
Benefits
Common myths
MythSince low testosterone correlates with worse cholesterol, raising testosterone will fix the lipid panel on its own.
FactA population-level correlation doesn't prove simple one-directional causality — part of the relationship stems from a shared background (obesity, insulin resistance), and the pharmacological effect of TRT itself on lipids is a separate phenomenon, covered in a dedicated entry.
MythLow testosterone always means a bad lipid panel, and vice versa.
FactThis is a population-level correlation, visible across large groups — not a rule that holds for every individual. An individual's lipid panel depends on many additional factors, including diet, genetics, and body weight.
Check your profile
Not sure which supplements actually make sense for you?
Answer a few short questions about your lifestyle, diet, sleep, and goals. VitMode will build your profile and show supplements worth considering — with reasoning and evidence strength.
Recommendations take your answers and the strength of the scientific evidence into account. A supplement's popularity has no bearing on whether it gets recommended.
Practice
Frequently asked questions
Population studies show a correlation — lower natural testosterone is linked to higher triglycerides and lower HDL — but they don't prove simple, one-directional causality. A significant part of this relationship may stem from a shared background of visceral obesity and insulin resistance.
This entry describes the broad, epidemiological relationship between natural testosterone level and lipids in a population of men not on hormone therapy. The specific, pharmacological effect of starting TRT on the lipid panel — with the exact direction and magnitude of changes — is covered separately, in our entry "TRT and Cholesterol."
Not necessarily in a direct, predictable way based on the population correlation alone. The pharmacological effect of testosterone therapy on lipids is a separate phenomenon, with its own well-described mechanism and direction of change — we cover it in detail in a dedicated entry.
What to combine with
Good combinations
TRT and Cholesterol — How Does Testosterone Affect Your Lipid Profile? — The specific direction and magnitude of lipid panel changes under pharmacological testosterone therapy — a distinctly different, narrower topic than the population correlation described here.
Lipid Panel — A full interpretation of individual lipid panel parameters outside the context of testosterone.
Safety
Side effects & contraindications
Possible side effects
Contraindications
No significant contraindications at typical doses.
Interactions
Visceral obesity — strongly correlates with both lower testosterone and an unfavorable lipid profile, independent of the hormone itself
Insulin resistance and metabolic syndrome — a common denominator behind low testosterone and elevated triglycerides
Low SHBG — a marker of metabolic disturbance, correlating with both phenomena at once
Statins and other lipid-lowering drugs — their effectiveness doesn't depend on a person's natural testosterone level
Is it worth taking?
Who it's for
- Men noticing a correlation between their own low testosterone and an unfavorable lipid panel, before even considering TRT
- People wanting to understand the difference between an epidemiological correlation and the pharmacological effect of therapy
Not for
- No significant contraindications at typical doses.
Evidence
Worth knowing
A Finnish study of more than 1,600 men found a positive correlation between testosterone and HDL, and a negative one with triglycerides and total cholesterol.
This relationship concerns natural, endogenous testosterone in a population, not the effect of replacement therapy.
Visceral obesity and insulin resistance are a common denominator behind both low testosterone and an unfavorable lipid profile.
Studies
Testosterone correlated positively with HDL cholesterol and negatively with total cholesterol and triglycerides, but not with LDL — in aging men, low testosterone was linked to a potentially atherogenic lipid profile.
Mäkinen J.I. et al., Atherosclerosis, 2008
Endogenous testosterone and serum lipids in middle-aged men
Moderate evidenceMäkinen J.I., Perheentupa A., Irjala K. et al. · Atherosclerosis · 2008
An observational study of 1,619 men aged 40–69 showing that natural testosterone correlates positively with HDL cholesterol and negatively with total cholesterol and triglycerides, but not with LDL. The authors note that low testosterone in aging men is linked to a potentially atherogenic lipid profile.
View studySources & bibliography
Citations are illustrative for this demo version and require full bibliographic verification by the editorial team before production publication.
Compare with similar entries
About the authors of this entry
Author
dr Katarzyna LewandowskaCardiologist
Katarzyna works as a cardiologist at a Warsaw teaching hospital and has spent years focused on cardiovascular prevention — trying, as she puts it, to convince people to change their habits before they end up on her ward, not after. She joined VitMode after a series of conversations with Anna at a lifestyle-medicine conference, where the two discovered they shared the same frustration: an internet full of contradictory claims about cholesterol, aspirin and heart supplements, with no clear signal of what's actually backed by research. She reviews content on cardiovascular health, lipid panels and pharmacological prevention, consistently distinguishing what helps a statistical population from what makes sense for a specific person. Off duty, she road-cycles — not for performance, but because, in her words, it's hard to write credibly about prevention without practicing it yourself.
35 publications on this site
Medical review
dr Piotr ZielińskiEndocrinologist
Piotr has practiced endocrinology for more than fifteen years, mostly in male hormonal disorders and metabolic health. He joined VitMode as a scientific consultant because, as he jokes, he got tired of explaining the same testosterone questions at every appointment and decided to write the answers down properly, once. He reviews content on hormone therapy, supplement pharmacology and drug interactions, making sure articles never turn into encouragement to self-supplement in situations that genuinely need diagnostics and medical supervision. His professional motto — "evidence first, enthusiasm second" — has come up more than once with a patient who arrived with a supplement plan they found online.
235 publications on this site
Related entries
4.5TRT and Cholesterol — How Does Testosterone Affect Your Lipid Profile?
Testosterone therapy usually lowers total cholesterol and LDL slightly, but it often lowers HDL too — which historically raised concern. We explain why these changes rarely translate into a real worsening of cardiovascular risk, and how to read a lipid panel in the context of TRT.
4.6Lipid Panel
The lipid panel is one of the most important — and still one of the most frequently misread — preventive blood tests: 'total cholesterol' alone tells you less than the ratios between its fractions.
4.7TRT (Testosterone Replacement Therapy) — What Is It and Who Is It For?
TRT isn't a supplement for fatigue — it's pharmacological treatment for a confirmed testosterone deficiency, with a real but limited list of benefits and an equally real list of people who simply don't qualify for it.
4.6Apolipoprotein B (ApoB)
While a standard lipid panel measures the amount of cholesterol carried in your blood, apolipoprotein B measures something different — the number of particles themselves that can actually penetrate the artery wall. That distinction can matter when a standard lipid panel looks fine but cardiovascular risk remains elevated.
4.7TRT — Side Effects and Therapy Monitoring
Erythrocytosis, fertility impact, PSA screening, and the cardiovascular risk question — what testosterone replacement therapy safety actually involves and how it's monitored.
4.7What Tests Are Needed Before TRT? The Complete Pre-Treatment Testing List
Before a physician can qualify a patient for testosterone therapy, a far broader panel of tests is needed than testosterone level alone. The full list of blood tests, symptom questionnaires, and criteria that determine whether TRT is safe and appropriate.
Related articles
PoradnikiHow to Raise HDL Cholesterol? 8 Ways Backed by Real Evidence
HDL is often called "good cholesterol," and the internet is full of advice on raising it — from supplements to drastic diets. The problem is that some of these methods really do raise the HDL number on your bloodwork, yet don't translate into lower risk of heart attack or stroke. We check eight concrete, researched ways to raise HDL — and honestly flag which of them also have evidence for real clinical benefit, and which simply move a number.
September 7, 2026
PoradnikiGarlic and LDL Cholesterol: Does It Really Lower It?
"Garlic lowers cholesterol" is one of the oldest folk health tips — and, rare for this category, partly confirmed by meta-analyses of clinical trials. But the devil is in the details: the effect is real (an LDL drop of about 9 mg/dL), yet it applies only to people with already elevated cholesterol, requires supplementation lasting more than 2 months, and has nothing to do with occasionally tossing a clove of garlic into dinner.
August 23, 2026
PoradnikiCinnamon and LDL Cholesterol: What Does the Meta-Analysis Actually Show?
Cinnamon is often marketed as a natural way to lower "bad" LDL cholesterol. A meta-analysis of 13 randomized trials involving 750 people, however, paints a more nuanced picture than the popular belief: cinnamon significantly lowers triglycerides and total cholesterol, but its effect on LDL specifically turned out to be statistically insignificant.
September 2, 2026
PoradnikiHow to Read Your Lipid Panel — Total Cholesterol Isn't the Whole Story
You get your lipid panel back, see "total cholesterol: normal," and close the topic? That might be premature. Total cholesterol is the sum of several fractions with very different clinical meaning, and a growing body of evidence suggests that the number of LDL particles (or apoB) says more about actual cardiovascular risk than the overall figure. This guide shows how to read a lipid panel line by line.
September 3, 2026
Comments (2)
- KW
Kasia W. 2 weeks ago
Very clearly explained, especially the interactions section — I hadn't seen it laid out this well anywhere else.
- MT
Marek T. a month ago
Are you planning to update this with the newest study from this year? I saw an interesting meta-analysis.